Literature DB >> 15287861

Tissue collection, transport and isolation procedures required to optimize human hepatocyte isolation from waste liver surgical resections. A multilaboratory study.

Lysiane Richert1, Eliane Alexandre, Tom Lloyd, Samantha Orr, Catherine Viollon-Abadie, Rakhee Patel, Shaun Kingston, David Berry, Ashley Dennison, Bruno Heyd, Georges Mantion, Daniel Jaeck.   

Abstract

BACKGROUND: The European Center for Validation of Alternative Methods (ECVAM) has funded a prevalidation study in three laboratories (France, USA and UK) on the use of human hepatocyte cultures to predict cytochrome P-450 induction. AIMS AND METHODS: As first stage of this prevalidation study, the purpose of the present work was to set criteria for optimization and harmonization of hepatocyte isolation from human tissue among laboratories to establish a routine procedure. This was achieved by combining and/or comparing the data generated by the two independent European laboratories (France and UK).
RESULTS: The results confirmed that surgical waste material is a valuable source for obtaining high quality hepatocytes under certain pre-, intra- and post-operative conditions: cell yield of viable hepatocytes was not significantly affected by age and sex of patients, nor indications for resection, steatosis or cholestasis. Cold ischeamia up to 5 hours did not influence viable cell yield allowing transport of material.
CONCLUSION: The use of biopsy sizes between 50-100 g, cannulation with 2-4 cannulae, digestion with collagenase-containing digestion medium at a flow rate of 25 ml/cannula for 20 minutes, with cut surface being glued in order to reform Glisson's capsule, should optimize the total yield of viable human hepatocytes obtained per preparation of waste liver surgical resections. Copyright Blackwell Munksgaard 2004

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287861     DOI: 10.1111/j.1478-3231.2004.0930.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  13 in total

Review 1.  The conduct of drug metabolism studies considered good practice (II): in vitro experiments.

Authors:  Lee Jia; Xiaodong Liu
Journal:  Curr Drug Metab       Date:  2007-12       Impact factor: 3.731

Review 2.  Cell sources for in vitro human liver cell culture models.

Authors:  Katrin Zeilinger; Nora Freyer; Georg Damm; Daniel Seehofer; Fanny Knöspel
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-05

Review 3.  Liver 'organ on a chip'.

Authors:  Colin H Beckwitt; Amanda M Clark; Sarah Wheeler; D Lansing Taylor; Donna B Stolz; Linda Griffith; Alan Wells
Journal:  Exp Cell Res       Date:  2017-12-29       Impact factor: 3.905

4.  Exploring donor demographics effects on hepatocyte yield and viability: Results of whole human liver isolation from one center.

Authors:  Sharon Geerts; Sinan Ozer; Chris Chu; Bryan C Fuchs; Kenneth K Tanabe; Heidi Yeh; Korkut Uygun
Journal:  Technology (Singap World Sci)       Date:  2019-04-26

5.  The liver prometastatic reaction of cancer patients: implications for microenvironment-dependent colon cancer gene regulation.

Authors:  Fernando Vidal-Vanaclocha
Journal:  Cancer Microenviron       Date:  2011-08-26

6.  Hepatocytes isolated from neoplastic liver-immunomagnetic purging as a new source for transplantation.

Authors:  Aravin Gunasegaram; Javed Akhter; Peng Yao; Loreena A Johnson; Stephen M Riodan; David L Morris
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

7.  Clinical Hepatocyte Transplantation: What Is Next?

Authors:  James E Squires; Kyle A Soltys; Patrick McKiernan; Robert H Squires; Stephen C Strom; Ira J Fox; Alejandro Soto-Gutierrez
Journal:  Curr Transplant Rep       Date:  2017-10-14

8.  An algorithm that predicts the viability and the yield of human hepatocytes isolated from remnant liver pieces obtained from liver resections.

Authors:  Serene M L Lee; Celine Schelcher; Rüdiger P Laubender; Natalja Fröse; Reinhard M K Thasler; Tobias S Schiergens; Ulrich Mansmann; Wolfgang E Thasler
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

9.  Liver tissue fragments obtained from males are the most promising source of human hepatocytes for cell-based therapies - Flow cytometric analysis of albumin expression.

Authors:  Karolina Ewa Zakrzewska; Anna Samluk; Agnieszka Wencel; Krzysztof Dudek; Dorota Genowefa Pijanowska; Krzysztof Dariusz Pluta
Journal:  PLoS One       Date:  2017-08-09       Impact factor: 3.240

10.  Hepatocyte isolation from unused/rejected livers for transplantation: initial step toward hepatocyte transplantation, the first experience from iran.

Authors:  Mahdokht Hossein Aghdaie; Bita Geramizadeh; Negar Azarpira; Elahe Esfandiari; Masoume Darai; Marjan Rahsaz; Saman Nikeghbalian; Seyed Ali Malekhosseini
Journal:  Hepat Mon       Date:  2013-08-03       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.